A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.

The University of Arizona and the Phoenix VA will open a medical research space this month at the College of Medicine in downtown Phoenix to help veterans with their medical needs. KTAR has aired this story 6 times between Dec. 9 & 10.

Medical experts are urging Pima County residents to stay home after hospitals hit capacity Wednesday night. "If we don't intervene, quickly, then we will, in fact, overwhelm our hospital system. Right now that's the critical weakness is we may not have room, in the end, for everybody come Christmas Day," said Joe Gerald, an associate professor in the University of Arizona's Mel and Enid Zuckerman College of Public Health.

As hospitals face a crisis because of the surging number of COVID-19 patients, most Arizonans have fewer restrictions on their day-to-day lives than they did during the first wave of the illness. "We're at a level of spread that is at or higher, arguably, depending on what variables you look at, as we were in our initial peak here in Arizona. At that time we had much more shutdown than we do now," said Dr. Farshad Fani Marvasti, a public health expert, physician and associate professor at the University of Arizona College of Medicine – Phoenix.

Inspired by her work at an orphanage, Dr. Katalin Gothard aims to understand how the brain interprets the social, emotional and physical aspects of touch.

Robert Norwood and Laurence Hurley have been elected as fellows of the academy, the organization's most prestigious designation.

In rural areas with limited access to X-ray machines and CT scans, lung ultrasound could help providers diagnose COVID-19 infections.

University of Arizona Health Sciences researchers are conducting a multiyear research study – Arizona CoVHORT – to answer questions about risk factors for severe COVID-19 infection and how the virus impacts long-term health outcomes.

President-elect Joe Biden's pandemic-response strategy took clearer shape this week with the rollout of several surprising appointments – a list that underscores that his COVID-19 response will be led far more by career government scientists and lower-level health agency deputies than has been the case during the Trump administration. "I don't think we should automatically assume things about a selection's lack of health-specific experience without also considering a few things: The Biden-Harris administration has been exceedingly science-focused, and often we have leaders with more policy experience to help navigate the field and allow them to listen more closely to the scientists," said Saskia Popescu, an epidemiologist and adjunct professor at the University of Arizona Mel and Enid Zuckerman College of Public Health.

The new COVID-19 vaccines from Pfizer and Moderna seem to be remarkably good at preventing serious illness. But it's unclear how well they will curb the spread of the coronavirus. "Preventing severe disease is easiest, preventing mild disease is harder, and preventing all infections is the hardest," said Deepta Bhattacharya, an immunologist at the University of Arizona College of Medicine - Tucson. "If it's 95% effective at preventing symptomatic disease, it's going to be something less than that in preventing all infections, for sure."